Skip to main content
Veterinary Medicines

Animedistin 12% N

Authorised
  • COLISTIN SULFATE

Product identification

Medicine name:
Animedistin 12% N
Active substance:
  • COLISTIN SULFATE
Target species:
  • Chicken
  • Pig
  • Cattle
  • Cattle (calf)
Route of administration:
  • In drinking water use
  • In-feed use
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    120.00
    gram(s)
    /
    1.00
    kilogram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        2
        day
  • In-feed use
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        2
        day
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industria Italiana Integratori Trei S.p.A.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6500762.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."